Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Pfizer reports identification of a new series of noradrenaline reuptake inhibitors

Aug. 7, 2008

Bristol-Myers Squibb describes creation of intranasal CGRP antagonist for migraine

Aug. 7, 2008

BMS-708163, a novel gamma-secretase inhibitor, has good pharmacological profile in animals, humans

Aug. 7, 2008

Abbott's A-887755 under development for passive immunotherapy in Alzheimer's disease

Aug. 7, 2008

PRX-03140 improves ADAS-Cog scores in Alzheimer's disease patients

Aug. 7, 2008

BioAlliance and APR sign European licensing agreement for ondansetron RapidFilm

Aug. 6, 2008

New agents for anxiety, psychosis, depression, etc. revealed in patent literature

Aug. 6, 2008

Senexis identifies promising beta-amyloid aggregation inhibitor

Aug. 6, 2008

New preclinical, phase I data on CTS-21166 made available

Aug. 6, 2008

Further phase II data on dimebon in Alzheimer's disease presented

Aug. 6, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...